Showing 6551-6560 of 7509 results for "".
- Sensus Healthcare Launches SRT-100 for Keloid Prevention and Treatment in Chinahttps://practicaldermatology.com/news/sensus-healthcare-launches-srt-100-in-china-for-keloid-prevention-and-treatment/2457985/Sensus Healthcare, Inc. launched the SRT-100™ in China for the treatment and prevention of keloids with Chindex Medical Limited. Sensus also announced the extension of its exclusive distribution agreement with Chindex M
- Is a Topical Gel Made From Oral Blood Pressure Drugs a Panacea for Wound Healing, Wrinkles and More?https://practicaldermatology.com/news/is-a-topical-gel-made-from-oral-blood-pressure-drugs-a-panacea-for-wound-healing-wrinkles-and-more/2457989/Topical gel made from angiotensin II receptor blockers may speed the healing of chronic skin wounds in mice and pigs, Johns Hopkins researchers report. The findings, published in the Journal of Investigative Dermatology, marks efforts to seek approval from the U.S. Food and Drug
- Abbvie's Risankizumab Performs Well in Three Phase Three Psoriasis Studieshttps://practicaldermatology.com/news/abbvies-risankizumab-performs-well-in-three-phase-three-psoriasis-studies/2457991/Top-line results from three pivotal Phase 3 clinical trials show that risankizumab, an investigational interleukin-23 (IL-23) inhibitor,
- Philips Rolls Out New Three-In-One Skincare Devicehttps://practicaldermatology.com/news/philips-rolls-out-new-three-in-one-skincare-device/2457997/Philips is introducing Philips VisaPure Advanced, a new three-in-one facial skincare tool. The new device works to remove impurities that have accumulated in pores resulting in lesser appearance of enlarged or clogged pores and blackheads, which c
- Dr. Daniel Siegel Joins DermTech's Advisory Boardhttps://practicaldermatology.com/news/dr-daniel-siegel-joins-dermtechs-advisory-board/2458000/DermTech, Inc., appointed Daniel M. Siegel, MD, to its Scientific Advisory Board. Dr. Siegel is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as a president of the American Academy of Dermatology (AAD) and is a pa
- Sun Dermatology Launches Absorica Tracker App to Help Patients Track Progresshttps://practicaldermatology.com/news/sun-dermatology-launches-absorica-tracker-app-to-help-patients-track-progress/2457999/Sun Pharma launched an Absorica Tracker App to help patients get the most out of their treatment. The easy-to-use interface is designed to help users to monitor their progress with Absorica (isotretinoin) treatment with features like medication and appointment reminders, monthly tips and checklis
- Menlo Therapeutics Expands Management Teamhttps://practicaldermatology.com/news/menlo-therapeutics-expands-management-team/2458006/Menlo Therapeutics Inc., a late stage biopharmaceutical company, is developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus associated with various underlying conditions, and for the treatment of refractory chronic cough. The company, which continues to ad
- FDA Clears Xstrahl Photoelectric Therapy Systemhttps://practicaldermatology.com/news/fda-clears-xstrahl-photoelectric-therapy-system/2458005/Xstrahl has received FDA 510K clearance for the marketing of its latest skin cancer therapy device. The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and surface electronic brachyt
- National Rosacea Society Awards New Grants; Call for 2018 Proposalshttps://practicaldermatology.com/news/national-rosacea-society-awards-new-grants/2458008/The National Rosacea Society (NRS) awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program. Dr. Benjamin Kaffenberger, MD assistant professor of dermatology at the Ohio
- Ortho Dermatologics: Long-term Efficacy Data for Siliqhttps://practicaldermatology.com/news/ortho-dermatologics-long-term-efficacy-data-for-siliq/2458009/Siliq™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years in patients with moderate-to-severe psoriasis, according to data presented at the 2017 Fall Clinical Dermatology Conference in Las Vegas and reported by